Apart from conventional markers such as AFP and PIVKA-II, the development of aMAP score, Glypican-3 (GPC-3) and golgiprotein73 (GP73) was also shown to be significant in HCC screening. This evidence concerns the gene GOLM1 and hepatocellular carcinoma.